Logo image of XELB

XCEL BRANDS INC (XELB) Stock Fundamental Analysis

NASDAQ:XELB - Nasdaq - US98400M2008 - Common Stock - Currency: USD

1.91  -0.04 (-2.05%)

After market: 1.91 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to XELB. XELB was compared to 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of XELB have multiple concerns. XELB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XELB has reported negative net income.
In the past year XELB has reported a negative cash flow from operations.
XELB had negative earnings in each of the past 5 years.
XELB had negative operating cash flow in 4 of the past 5 years.
XELB Yearly Net Income VS EBIT VS OCF VS FCFXELB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

XELB has a Return On Assets of -36.01%. This is amonst the worse of the industry: XELB underperforms 91.67% of its industry peers.
XELB has a Return On Equity of -68.14%. This is in the lower half of the industry: XELB underperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -36.01%
ROE -68.14%
ROIC N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
XELB Yearly ROA, ROE, ROICXELB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

XELB's Gross Margin of 105.50% is amongst the best of the industry. XELB outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of XELB has grown nicely.
The Profit Margin and Operating Margin are not available for XELB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 105.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
XELB Yearly Profit, Operating, Gross MarginsXELB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XELB has less shares outstanding
The number of shares outstanding for XELB has been reduced compared to 5 years ago.
XELB has a worse debt/assets ratio than last year.
XELB Yearly Shares OutstandingXELB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
XELB Yearly Total Debt VS Total AssetsXELB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

XELB has an Altman-Z score of -2.56. This is a bad value and indicates that XELB is not financially healthy and even has some risk of bankruptcy.
XELB has a worse Altman-Z score (-2.56) than 87.50% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that XELB is not too dependend on debt financing.
XELB has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -2.56
ROIC/WACCN/A
WACC10.49%
XELB Yearly LT Debt VS Equity VS FCFXELB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.28 indicates that XELB may have some problems paying its short term obligations.
XELB's Current ratio of 0.28 is on the low side compared to the rest of the industry. XELB is outperformed by 97.50% of its industry peers.
XELB has a Quick Ratio of 0.28. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
XELB has a worse Quick ratio (0.28) than 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
XELB Yearly Current Assets VS Current LiabilitesXELB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

XELB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.44%, which is quite impressive.
The Revenue for XELB has decreased by -46.68% in the past year. This is quite bad
The Revenue for XELB have been decreasing by -27.67% on average. This is quite bad
EPS 1Y (TTM)65.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.56%
Revenue 1Y (TTM)-46.68%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-39.01%

3.2 Future

The Earnings Per Share is expected to grow by 53.50% on average over the next years. This is a very strong growth
Based on estimates for the next years, XELB will show a very strong growth in Revenue. The Revenue will grow by 45.26% on average per year.
EPS Next Y49.22%
EPS Next 2Y53.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year64.89%
Revenue Next 2Y45.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XELB Yearly Revenue VS EstimatesXELB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
XELB Yearly EPS VS EstimatesXELB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XELB. In the last year negative earnings were reported.
XELB is valuated cheaply with a Price/Forward Earnings ratio of 2.34.
97.50% of the companies in the same industry are more expensive than XELB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.39. XELB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 2.34
XELB Price Earnings VS Forward Price EarningsXELB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XELB Per share dataXELB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

XELB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XELB's earnings are expected to grow with 53.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.5%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XELB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XCEL BRANDS INC

NASDAQ:XELB (6/10/2025, 8:17:31 PM)

After market: 1.91 0 (0%)

1.91

-0.04 (-2.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners25.19%
Inst Owner Change-92.83%
Ins Owners38.6%
Ins Owner Change3.93%
Market Cap4.56M
Analysts82.86
Price Target17.85 (834.55%)
Short Float %4.04%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.7%
Min EPS beat(2)-3.39%
Max EPS beat(2)28.79%
EPS beat(4)3
Avg EPS beat(4)41.98%
Min EPS beat(4)-3.39%
Max EPS beat(4)87.75%
EPS beat(8)7
Avg EPS beat(8)37.54%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-40.41%
Min Revenue beat(2)-43.05%
Max Revenue beat(2)-37.78%
Revenue beat(4)1
Avg Revenue beat(4)-21.19%
Min Revenue beat(4)-43.05%
Max Revenue beat(4)7.72%
Revenue beat(8)2
Avg Revenue beat(8)-11.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)833.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1087.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-986.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.34
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.97
EYN/A
EPS(NY)0.82
Fwd EY42.72%
FCF(TTM)-1.53
FCFYN/A
OCF(TTM)-1.48
OCFYN/A
SpS3.1
BVpS11.61
TBVpS-2.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.01%
ROE -68.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 105.5%
FCFM N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z -2.56
F-Score3
WACC10.49%
ROIC/WACCN/A
Cap/Depr(3y)2.47%
Cap/Depr(5y)7.52%
Cap/Sales(3y)0.99%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.56%
EPS Next Y49.22%
EPS Next 2Y53.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-46.68%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-39.01%
Revenue Next Year64.89%
Revenue Next 2Y45.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.16%
OCF growth 3YN/A
OCF growth 5YN/A